Literature DB >> 5111112

Diagnostic value of gamma-glutamyl transpeptidase and alkaline phosphatase in liver metastases.

H Baden, B Andersen, G Augustenborg, H K Hanel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5111112

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


× No keyword cloud information.
  7 in total

1.  Liver function tests in patients with computed tomography demonstrated hepatic metastases.

Authors:  M D Ottmar; R L Gonda; K J Leithauser; O H Gutierrez
Journal:  Gastrointest Radiol       Date:  1989

Review 2.  Is serum gamma-glutamyltransferase a misleading test?

Authors:  R Penn; D J Worthington
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-12

3.  A prospective analysis of laboratory tests and imaging studies to detect hepatic lesions.

Authors:  M M Kemeny; P H Sugarbaker; T J Smith; B K Edwards; T Shawker; M Vermess; A E Jones
Journal:  Ann Surg       Date:  1982-02       Impact factor: 12.969

4.  Screening for liver metastases from colorectal cancer with carcinoembryonic antigen and alkaline phosphatase.

Authors:  P I Tartter; G Slater; I Gelernt; A H Aufses
Journal:  Ann Surg       Date:  1981-03       Impact factor: 12.969

5.  TREM-1 activation is a potential key regulator in driving severe pathogenesis of enterovirus A71 infection.

Authors:  Siti Naqiah Amrun; Jeslin J L Tan; Natasha Y Rickett; Jonathan A Cox; Bernett Lee; Michael J Griffiths; Tom Solomon; David Perera; Mong How Ooi; Julian A Hiscox; Lisa F P Ng
Journal:  Sci Rep       Date:  2020-03-02       Impact factor: 4.379

6.  Carcinoembryonic antigen and glucose phosphate isomerase in a human colonic cancer model (GW-39).

Authors:  D Munjal; D M Goldenberg
Journal:  Br J Cancer       Date:  1976-09       Impact factor: 7.640

7.  Combination of carcinoembryonic antigen and gamma glutamyl transpeptidase in the study of the evolution of colorectal cancer.

Authors:  L Steele; E H Cooper; A M Mackay; M S Losowsky; J C Goligher
Journal:  Br J Cancer       Date:  1974-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.